Clinical Nutrition Research Centre
Singapore, 117599
NCT Number: NCT03503552
This project aims to ascertain that novel imaging and metabolic markers can be used to identify as well as to validate and improve the detection of Singapore-Chinese women at increased risk of diabetes.
Looking for future studies?
Notify Me55 year–70 year
Female
Observational
Singapore, 117599
Disproportionate non-communicable disease risk present in some ethnicities has been demonstrated and is amplified by increased weight gain. Relative to Malay and Caucasian populations, the prevalence of obesity increased sharply in people of Chinese and Indian ethnicity and diabetes risk is prevalent at a BMI of 21 (equivalent to a BMI >25 in Caucasian populations). It was also speculated that Chinese Singaporean women are prone to metabolic syndrome at a lower BMI. This study will recruit two groups of postmenopausal women with different BMI's and to measure markers for metabolic syndrome. These participants will visit Clinical Nutrition Research Centre for a single session and will undergo a whole body scan and a regional scan of the lumbar spine and femoral neck with a bone densitometer and fasting baseline blood and urine samples collected. Dual Energy X-ray Absorptiometry (DEXA) scan will provide percentage fat mass, fat in gram, whole body bone mineral content and total body lean mass. From these, gynoid and android fat distribution will be derived and appendicular lean mass will be calculated and an index calculated using kg/m2 to give an indication of relative muscle mass. In addition blood and urine samples will be collected for metabolic risk analysis. Participants will be also be undergoing a Quantitative Computed Tomography (QCT) scan which will allow true volumetric measurements of the lumbar spine and proximal femur independent of the body size. Volumetric density values will be measured in Hounsfield units transformed into Bone Mineral Density measurements using a calibration phantom underneath the patient. Magnetic Resonance Imaging of the 3rd lumbar vertebra and the right hip will also be performed.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 hour
Measured using Air Displacement Plethysmograph (BOD POD)
Time frame: 1 hour
Measured using Dual Energy X-Ray Absorptiometry
Time frame: 1 hour
Measured using Magnetic Resonance Imaging (MRI)
Time frame: Half an hour
Measured using Dual Energy X-Ray Absorptiometry (DEXA)
Time frame: Half an hour
Measured using Quantitative Computed Tomography
Time frame: Half an hour
Measured using Magnetic Resonance Imaging (MRI)
Time frame: Half an hour
Measure of fasting blood glucose
Time frame: Half an hour
Measure of fasting blood insulin
Time frame: Half an hour
Measure of fasting blood lipid profile
Time frame: Half an hour
Measure of fasting apolipoprotein A1
Time frame: Half an hour
Measure of fasting apolipoprotein B
Time frame: Half an hour
Measure of folate
Time frame: Half an hour
Measure of vitamin B12
Time frame: Half an hour
Measure of high-sensitive C-reactive protein
Time frame: Half an hour
Measure of Parathyroid hormone
Time frame: Half an hour
Measure urinary C-telopeptide of type II collagen
JeyaKumar Henry
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03344718
Atrophy, Avitaminosis
Tainan, Taiwan
View Trial DetailsNCT03483584
Avitaminosis, Bone Diseases
Shatin, Hong Kong
View Trial DetailsNCT04472286
Acute Lymphoblastic Leukemia, Pediatric, Bone Diseases
Omaha, Nebraska, United States
View Trial DetailsNCT04488432
Adrenal Gland Diseases, Adrenal Insufficiency
Brest, France
View Trial Details